The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer

Oncology Reports

Volumn 30, Issue 2, 2013, Pages 651-658

  He, Hang ^a   Di, Yang ^a   Liang, Minrui ^a   Yang, Feng ^a   Yao, Lie ^a   Hao, Sijie ^a   Li, Ji ^a   Jiang, Yongjian ^a   Jin, Chen ^a   Fu, Deliang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Lymphatic metastasis; microRNA; Pancreatic cancer

Indexed keywords

LET 7; MICRORNA; MICRORNA 145; MICRORNA 218; MICRORNA 663; ROBO 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BIRC5 GENE; CANCER SCREENING; CETN2 GENE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EGFR GENE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HISTOPATHOLOGY; HOXA1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LAMB3 GENE; LEF1 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PANCREAS ACINUS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PAXILLIN GENE; PRECANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; ROBO 1 GENE; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NERVE TISSUE PROTEINS; PANCREATIC NEOPLASMS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84879649031     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2516     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu JQ and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM and Chen J: The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31: 1726-1733, 2010.
3. Yu SN, Lu ZH, Liu CZ, et al: miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 70: 6015-6025, 2010.
4. Torrisani J, Bournet B, du Rieu MC, et al: Let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 20: 831-844, 2009.
5. Ji Q, Hao X, Zhang M, et al: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4: e6816, 2009.
6. Radhakrishnan P, Mohr AM, Grandgenet PM and Hollingsworth MA: MicroRNA-200c modulates the expression of MUC4 and MUC16 in human pancreatic cancer. The 42nd Annual Meeting of the American Pancreatic Association. Pancreas 40: 1350, 2011.
7. Bhatti I, Lee A, James V, et al: Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 15: 199-208, 2011.
8. Song L, Huang Q, Chen K, et al: miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun 402: 135-140, 2010.
9. Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG and Maitra A: Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology 10: 66-73, 2010.
10. Szafranska AE, Davison TS, John J, et al: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26: 4442-4452, 2007. (Pubitemid 47014466)
11. Lee EJ, Gusev Y, Jiang J, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007. (Pubitemid 46214304)
12. Bloomston M, Frankel WL, Petrocca F, et al: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908, 2007. (Pubitemid 46707844)
13. Srivastava SK, Bhardwaj A, Singh S, et al: MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 32: 1832-1839, 2011.
14. Ohuchida K, Mizumoto K, Kayashima T, et al: MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Ann Surg Oncol 18: 2381-2387, 2011.
15. Nakata K, Ohuchida K, Mizumoto K, et al: MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 150: 916-922, 2011.
16. Liffers ST, Munding JB, Vogt M, et al: MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91: 1472-1479, 2011.
17. Hao J, Zhang SY, Zhou YQ, Liu C, Hu XG and Shao CH: MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406: 552-557, 2011.
18. Giovannetti E, Funel N, Peters GJ, et al: MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 70: 4528-4538, 2010.
19. Luo GP, Yu XJ, Jin C, et al: LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int J Pharm 385: 150-156, 2010.
20. Yang F, Jin C, Yang D, et al: Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. Eur J Cancer 47: 1873-1882, 2011.
21. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993. (Pubitemid 24014542)
22. Hwang JH, Voortman J, Giovannetti E, et al: Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 5: e10630, 2010.
23. Kim HR, Jang SE, Beik WH, Lee SH and Hwang JH: Chemosensitivity of indole-3-carbinol via downregulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells. Asian Pacific Digestive Week, Oct, 2011. J Gastroen Hepatol 26: 232, 2011.
24. Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A and Capussotti L: Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol 16: 3323-3332, 2009.
25. Riediger H, Keck T, Wellner U, et al: The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13: 1337-1344, 2009.
26. Yachida S, Jones S, Bozic I, et al: Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117, 2010.
27. Uesugi A, Kozaki K, Tsuruta T, et al: The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 71: 5765-5778, 2011.
28. Tatarano S, Chiyomaru T, Kawakami K, et al: miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21, 2011.
29. Leite KRM, Sousa-Canavez JM, Reis ST, et al: Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 29: 265-269, 2011.
30. Alajez NM, Lenarduzzi M, Ito E, et al: MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71: 2381-2391, 2011.
31. Gao CP, Zhang ZY, Liu WZ, Xiao SD, Gu WQ and Lu H: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 116: 41-49, 2010.
32. Davidson MR, Larsen JE, Yang IA, et al: MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 5: e12560, 2010.
33. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582, 2008. (Pubitemid 351550884)
34. Tie J, Pan YL, Zhao LN, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
35. Wu DW, Cheng YW, Wang J, Chen CY and Lee H: Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 70: 10392-10401, 2010.
36. Zhou XY, Chen XJ, Hu LM, et al: Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol 117: 287-290, 2010.
37. Noel LS, Champion BR, Holley CL, et al: RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/ Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage. J Biol Chem 273: 3878-3883, 1998. (Pubitemid 28103244)
38. Ploug M and Ellis V: Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom α-neurotoxins. FEBS Lett 349: 163-168, 1994.
39. Yang L, Li Q, Wang Q, Jiang Z and Zhang L: Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway. Biomed Pharmacother 66: 535-540, 2012.
40. Woo S, Fish JE, Wythe JD, Bruneau BB, Stainier DY and Srivastava D: A novel Slit-Robo-miR-218 signaling axis regulates VEGF-mediated heart tube formation in zebrafish. The 69th Annual Meeting of the Society for Developmental Biology/ Japanese Society of Developmental Biologists. Dev Biol 344: 433, 2010.